| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.2B | $6.9B | $6.4B | $6.9B | $5.7B | $1.2B | $1.6B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.2B | $0.3B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | $0.4B |
| Operating Income | — | — | — | — | — | — | — | $0.3B |
| Net Income | $0.4B | $0.7B | $0.6B | $0.8B | $0.6B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.28 | $8.70 | $7.25 | $9.35 | $6.22 | $1.16 | $1.37 | $1.09 |
| EPS (Diluted) | $6.15 | $8.45 | $7.03 | $9.09 | $6.01 | $1.12 | $1.31 | $0.96 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.7B | $6.9B | $6.6B | $6.7B | $5.8B | $5.4B | $5.0B | $5.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | $0.3B | $0.3B | $0.7B | $0.5B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.9B | $4.1B | $3.8B | $3.7B | $3.0B | $2.7B | $2.4B | $2.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $1.1B | $0.2B | $-0.0B | $0.3B | $0.3B | $0.2B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.0B | $-0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — | — |
| Financing Cash Flow | $-0.6B | $-0.4B | $-0.6B | $-0.1B | $-0.3B | $-0.1B | $-0.3B | $-0.3B |